In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series C brings in $150mm for Valeritas

Executive Summary

Valeritas Inc. (insulin delivery technology) has raised a whopping $150mm in its Series C venture round led by Welsh, Carson, Anderson & Stowe, which takes a controlling interest in the company following the financing. The investment firm's Daniel Pelaki will become chairman of the company’s board. Also contributing were returning shareholders Abingworth, Advanced Technology Ventures, Agate Medical Investments, CHL Medical Partners, HLM Venture Partners, Kaiser Permanente Ventures, MPM Capital, Onset Ventures, and Pitango Venture Capital.

Deal Industry
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Macromolecule
      • Transdermal
  • Biotechnology
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies